Raquel Laza-Briviesca

4PUBLICATIONS
47CO-AUTHORS
AutoimmunityGenetic immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 09, 2024
The 'Treg paradox' in inflammatory arthritis.

Julia T Schnell, Raquel Laza Briviesca, Taehyeung Kim

|Mar 08, 2024
Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development.

Taehyeung Kim, Marta Martínez-Bonet, Qiang Wang

|Apr 08, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC.

Pedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca

|Jul 29, 2021
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.

Raquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal

Pageof 1